Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Jayashri Kulkarni, Kate Reeve-Parker

Abstract

The Adherence in Schizophrenia (ADHES) initiative aimed to assess physicians' perspectives about treatment adherence in people with schizophrenia, and assess strategies to improve adherence. Between March and April 2012, a 20-question survey was delivered to Australian psychiatrists (n = 3400). These anonymous surveys were returned by mail. The survey asked about the demographics of participating psychiatrists and the respondents' perceptions of different factors that affect the adherence of people with schizophrenia to their treatment with antipsychotic medications. Adherence was defined by the proportion of prescribed doses taken: non-adherence, if < 30%; partial-adherence, 30%-90%; and adherent, > 90%. Data were reported descriptively and were not weighted. Respondent psychiatrists (n = 406; response rate 12%) reported that one-half (51%) of people with schizophrenia were either non-adherent (20%) or only partially adherent (31%). This was despite most (72%) psychiatrists' reporting that they assessed adherence to medication at every visit. The main reported reasons for medication discontinuation were: lack of insight (45%), drug or alcohol abuse (3%), or side effects (29%). The preferred strategies for improving adherence w...Continue Reading

References

Jun 8, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·Virginija Novak-Grubic, Rok Tavcar
Jan 8, 2004·Journal of Clinical Psychopharmacology·Tim LambertRobert R Conley
Apr 26, 2006·Nordic Journal of Psychiatry·Jesper Dam
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Nov 4, 2006·The Journal of Clinical Psychiatry·L Fredrik Jarskog, Jeffrey A Lieberman
Nov 30, 2006·Human Psychopharmacology·Sung-Wan KimSung-Ku Choi
Mar 16, 2007·Acta Psychiatrica Scandinavica·H A Nasrallah
Nov 7, 2007·CNS Spectrums·John M Kane
Jun 24, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·S HeresW Kissling
Mar 5, 2011·Critical Reviews in Oncology/hematology·Gareth J Morgan
Sep 12, 2012·Schizophrenia Research and Treatment·Eduard ParelladaWerner Kissling
Jan 5, 2013·Clinical Drug Investigation·Fernando CañasMiquel Roca
Apr 6, 2013·The American Journal of Psychiatry·Nancy C AndreasenBeng-Choon Ho

❮ Previous
Next ❯

Citations

Jan 8, 2019·Chemistry & Biodiversity·Marissa Robles-MartínezRosalba Patiño-Herrera
Aug 1, 2015·Archives of Sexual Behavior·Stephen Cranney
Aug 2, 2017·Journal of Medical Economics·Thomas R EinarsonPieter J T Dries

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here